200 related articles for article (PubMed ID: 3061836)
1. Recombinant interferon-alpha-2b treatment of hairy-cell leukaemia: experience with a low-dose schedule.
Hasselbalch H; Braide I; Lisse I; Röckert LL; Swolin B; Carneskog J; Hagberg H; Hippe E; Jensen MK; Lundin P
Eur J Haematol; 1988 Nov; 41(5):438-44. PubMed ID: 3061836
[TBL] [Abstract][Full Text] [Related]
2. Long-term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian Cooperative Group for HCL.
Federico M; Frassoldati A; Lamparelli T; Foà R; Brugiatelli M; Annino L; Baldini L; Capnist G; Chisesi T; di Celle PF
Ann Oncol; 1994 Oct; 5(8):725-31. PubMed ID: 7826905
[TBL] [Abstract][Full Text] [Related]
3. Treatment of hairy cell leukemia with granulocyte colony-stimulating factor and recombinant consensus interferon or recombinant interferon-alpha-2b.
Glaspy JA; Souza L; Scates S; Narachi M; Blatt L; Ambersley J; Golde DW
J Immunother (1991); 1992 Apr; 11(3):198-208. PubMed ID: 1381218
[TBL] [Abstract][Full Text] [Related]
4. Relapse after interferon alfa-2b therapy for hairy-cell leukemia: analysis of prognostic variables.
Ratain MJ; Golomb HM; Vardiman JW; Westbrook CA; Barker C; Hooberman A; Bitter MA; Daly K
J Clin Oncol; 1988 Nov; 6(11):1714-21. PubMed ID: 3054003
[TBL] [Abstract][Full Text] [Related]
5. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
[TBL] [Abstract][Full Text] [Related]
6. The alpha 2 (r) interferon in the treatment of hairy cell leukemia: progressive report of 25 cases.
Mandelli F; Cafolla A; Annino L; Amadori S; Gentile A; Bianco P; Dianzani F
J Biol Regul Homeost Agents; 1987; 1(4):177-82. PubMed ID: 3332545
[TBL] [Abstract][Full Text] [Related]
7. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
8. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
[TBL] [Abstract][Full Text] [Related]
10. [Results of treatment in patients with hairy cell leukemia with splenectomy, alpha-interferon and deoxycoformycin].
Gotić M; Rolović Z; Radosević N; Draguljac N; Jovanović V; Bogdanović A; Bosković D
Srp Arh Celok Lek; 2000; 128(7-8):262-70. PubMed ID: 11089434
[TBL] [Abstract][Full Text] [Related]
11. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
Damasio EE; Frassoldati A
Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
[TBL] [Abstract][Full Text] [Related]
12. Splenectomy after initial therapy with alpha-IFN in patients with hairy-cell leukemia (HCL): a multi-center study by the Italian Cooperative Group for HCL. Preliminary results.
Damasio EE; Federico M; Frassoldati A; Lamparelli T; Annino L; Bernasconi C; Chisesi T; Foá R; Lauria F; Pagnucco G
Eur J Haematol Suppl; 1990; 52():29-31. PubMed ID: 2279542
[TBL] [Abstract][Full Text] [Related]
13. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
Ratain MJ; Golomb HM; Bardawil RG; Vardiman JW; Westbrook CA; Kaminer LS; Lembersky BC; Bitter MA; Daly K
Blood; 1987 Mar; 69(3):872-7. PubMed ID: 3814819
[TBL] [Abstract][Full Text] [Related]
14. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
Troussard X; Flandrin G
Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
[TBL] [Abstract][Full Text] [Related]
15. Sequential evaluation of alpha-2b-interferon treatment in 128 patients with hairy cell leukemia.
Golomb HM; Fefer A; Golde DW; Ozer H; Portlock C; Silber R; Rappeport J; Ratain MJ; Thompson J; Bonnem EM
Semin Oncol; 1987 Jun; 14(2 Suppl 2):13-7. PubMed ID: 3589701
[TBL] [Abstract][Full Text] [Related]
16. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
Kloke O; May D; Wandl U; Niederle N
Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
[TBL] [Abstract][Full Text] [Related]
17. Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
Lauria F; Foà R; Raspadori D; Zinzani PL; Buzzi M; Fierro MT; Bonferroni M; Fanin R; Gallizia C; Michieli MG
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):195-200. PubMed ID: 3356206
[TBL] [Abstract][Full Text] [Related]
18. Very low dose alpha-2b interferon for the treatment of hairy cell leukemia.
Thompson JA; Kidd P; Rubin E; Fefer A
Blood; 1989 May; 73(6):1440-3. PubMed ID: 2713488
[TBL] [Abstract][Full Text] [Related]
19. Sequential administration of recombinant interferon alpha and deoxycoformycin in the treatment of hairy cell leukaemia.
Habermann TM; Andersen JW; Cassileth PA; Bennett JM; Oken MM
Br J Haematol; 1992 Apr; 80(4):466-71. PubMed ID: 1581231
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]